Publications by authors named "A Elosua-Gonzalez"
Article Synopsis
- The study evaluates the effectiveness and safety of biological therapies for inflammatory bowel disease (IBD) in patients aged 65 and older, addressing a gap in existing research primarily focused on younger populations.
- A total of 1,090 elderly patients were included, with findings showing that a significant portion achieved clinical remission after treatment, particularly by the 52-week mark.
- Although the therapies were generally safe, there was a notable occurrence of oncological events, with variations in incidence rates depending on the specific treatment used.
Background And Aims: small bowel capsule endoscopy (SBCE) does not reach the cecum within the battery lifetime in approximately 15-35 % of patients. Incomplete examinations result in diagnostic delays and increase the economic burden. To date, risk factors for incomplete examinations have been described with contradictory results.
View Article and Find Full Text PDFArticle Synopsis
- The study aimed to identify factors that lead to poor wound healing in patients with perianal Crohn's disease after undergoing proctectomy, particularly in the context of biologic therapies.
- A review of 103 patient records revealed that 58.3% experienced wound healing failure at 6 months, and 39.8% at 12 months, with male gender being the only significant predictor of poor healing.
- The findings indicated that prior exposure to biologic therapies like infliximab and adalimumab was not linked to wound healing outcomes, while lower pre-operative C-reactive protein levels were associated with better healing at 6 months.
Introduction: Small bowel capsule endoscopy (SBCE) is a non-invasive diagnostic technique whose use in inflammatory bowel disease (IBD) has spread. A panenteric capsule, PillCam Crohn's (PCC), has recently been developed. We lack information on the availability and use of the CEID and PCC in our environment.
View Article and Find Full Text PDFIntroduction: Gastric premalignant conditions (GPC) surveillance has been proposed to improve the prognosis of gastric cancer (GC), but the early GC detection rate remaining low, and missing GC during an esophago-gastro-duodenoscopy is still a problem. We aimed to explore the gastroenterologists' attitudes on the detection and management of GPC.
Methods: A cross-sectional study was designed based on a survey among gastroenterologists from Asociación Española de Gastroenterología.